Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2020-06-02 Director's Dealing
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 215.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of securities held before and after the change, the nature of the change (on-market trade), and confirms no trading during a closed period. This is a report of personal share transactions by a company director, which fits the definition of 'Director's Dealing'. The document length is 3267 characters, which is consistent with a detailed notice rather than a brief announcement or a full report like an annual report or earnings release. Therefore, the correct classification is DIRS (Director's Dealing).
2020-06-02 English
Change of Director's Interest Notice 4 pages 265.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the interest, and transaction details. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other financial report type. It is a regulatory filing specific to director share transactions.
2020-06-02 English
Change of Director's Interest Notice 3 pages 241.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the interest, and transaction details. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor a full financial report, but a specific regulatory filing about director share transactions.
2020-06-02 English
Change in substantial holding 5 pages 341.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of Change of Interests of Substantial Holder filed under the Corporations Act 2001. It details changes in voting power and relevant interests of The Bank of New York Mellon Corporation and its group entities in Genetic Technologies Limited. The document includes dates of changes, previous and present voting power percentages, and annexures listing associated entities and relevant interests. There are no financial statements, earnings data, or management commentary. The document is a regulatory filing notifying changes in substantial shareholdings, which fits the category of Major Shareholding Notification (MRQ). The document length (8475 characters) supports it being a full notice rather than a brief announcement or certification. Therefore, the appropriate classification is MRQ with high confidence.
2020-05-31 English
Proposed issue of Securities - GTG 5 pages 26.1KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Proposed issue of securities' and details a placement or other type of securities issuance by Genetic Technologies Limited. It includes specifics such as the number of securities, issue price, approval requirements, and timetable for the proposed issue. The content focuses on the announcement of a capital raising event and the issuance of new warrants, which aligns with updates on company fundraising and capital structure changes. There are no financial statements or detailed financial performance data present, so it is not an Annual Report or Interim Report. The document is not a regulatory certification or a report publication announcement but a direct announcement of a capital raising event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-05-31 English
Section 708A Notice 1 page 104.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX Market Announcement titled 'Section 708A(5)(e) Notification' related to the issue of ordinary shares by Genetic Technologies Limited. It references compliance with the Corporations Act 2001 regarding the exemption for on-sale of securities issued without disclosure. The content is a formal notification about a share issue and legal compliance, not a financial report or detailed analysis. The document length is short (1533 characters), and it serves as a regulatory announcement about capital raising under specific legal provisions. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2020-05-31 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.